Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Company Profile - Grunenthal Ltd

Grunenthal Ltd

Grunenthal Ltd profile logo

Head Office

2 Beacon Heights Business Park
Ibstone Road

HP14 3XR

Tel: +44 (0) 8703 518 960

Fax: +44 (0) 8703 518 965


About Us

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.  We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.   Our portfolio covers a broad range of highly effective products indicated for both chronic pain conditions and acute pain conditions.


Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Australia, Latin America and the US.  Grünenthal products are sold in more than 155 countries and approx. 5,200 employees are working for the Grünenthal Group worldwide.


Our fields of therapy include


  • Pain (Prescriptive drugs)
  • Further indications

Latin America

  • Pain
  • Central nervous system
  • Gynaecolgy
  • Further Indications

Research and Development

  • Pain
  • Inflammation




Pain is the most single common reason why an individual consults a medical professional. The European Pain Federation (EFIC®) states that, whereas acute pain may reasonably be considered a symptom of disease or injury, chronic and recurrent pain is a specific healthcare problem, a disease in its own right. Pain and especially chronic pain can have a significant negative impact on you and your loved ones quality of life.


Grünenthal in the UK

Grünenthal UK Ltd, a subsidiary of Grünenthal GmbH, was established in 2004. With headquarters in Stokenchurch, Buckinghamshire, the company has grown rapidly and now employs over 130 people. This includes regulatory and medical information, sales and marketing divisions as well as market access and a medical science liaison team.

Grünenthal UK Ltd currently markets medications for the treatment of moderate to severe pain and for post herpetic neuralgia (PHN) to GPs, hospital doctors, pharmacists and nurses.


Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.